ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, IRadimed Corporation (IRMD) shows an Average True Range (ATR) of 1.65 and an Enterprise Value of 489.69M. Its average trading volume over the past 3 months is 47.34K, indicating liquidity. These fundamental metrics provide insight into IRMD's underlying financial health and market activity.
IRadimed Corporation (IRMD) technical indicators as of July 20, 2025: the SMA 20 is -4.48%, SMA 50 at -1.06%, and SMA 200 at 3.5%. The RSI 14 value is 40.35, suggesting its current momentum. These technical analysis signals help assess IRMD's price trends and potential future movements.
IRadimed Corporation (IRMD) stock performance overview as of July 20, 2025: The 52-week high is $63.29 (currently -10.43% below), and the 52-week low is $42.34 (currently 33.89% above). Over the past year, IRMD's performance is 23.35%, compared to the S&P 500's 13.57% change.
According to market data, IRadimed Corporation (IRMD) stock's recent performance metrics show that over the last month, IRMD is -2.22%, with a Year-to-Date (YTD) performance of 3.07%. Over the past year, the stock has seen a 23.35% change. These figures summarize IRMD's price movements across various periods, reflecting its historical returns.
According to current financial data, IRMD stock's P/E (TTM) ratio is 36.43, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for IRMD, including P/S (9.59), P/B (8.00), and P/FCF (51.49), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.